Stem cells are undifferentiated cells which
are capable of differentiating into any type of cell that make-up the human
body and thus, are capable of producing non-regenerative cells such as neural
and myocardial cells. This report estimates the market for global stem cells in
terms of revenue (USD billion) for the period 2012 – 2018, keeping 2011 as the
base year. The global stem cells market is mainly segmented into four major
sub-types namely market by products, market by technology, market by
applications and market by geography.
Browse Report With Full TOC : Stem
Cells Market
The market by products is segmented into
three sub-types, namely adult stem cells, human embryonic stem cells and other
type of stem cells. Adult stem cells are further segmented into hematopoietic
stem cells, mesenchymal stem cells, neuronal stem cells, dental stem cells and
umbilical cord stem cells. The other types of stem cells include induced
pluripotent stem cells, natural rosette cells and very small embryonic like
stem cells.
The global stem cells market by technology
is segmented into four sub-types, namely cell acquisition, cell production,
cryopreservation and expansion and sub-culture. Cell acquisition
is further segmented into three sub-types,
namely bone marrow harvest, apheresis and umbilical cord blood. Cell production
is further segmented into therapeutic cloning, in vitro fertilization,
isolation and cell culture.
The global stem cells market by application
is segmented into regenerative medicines and drug discovery and development.
Regenerative medicines are further segmented into ten sub-types, namely
neurological disorders, orthopedics, cancer, hematological disorders,
cardiovascular diseases, injuries, diabetes, liver disorders, incontinence and
other disorders like Crohn’s disease, infertility, immunodeficiency disorders
and organ transplants.
The global stem cells market is also
segmented on the basis of geography into North America, Europe, Asia and rest
of the world (RoW) regions and the market in terms of USD billion is provided
in this report.
The report highlights the market shares of
key players in 2011. The company profiles for some of the key players, namely
Advanced Cell Technology Inc., STEMCELL Technologies Inc., Cellular Engineering
Technologies Inc., BioTime Inc., Aastrom Biosciences Inc. and California Stem
Cell Inc. in terms of company overview, financial overview, business
strategies, recent developments and product portfolio is also covered.
The global stem cells market is
categorized into the following segments:
- Stem
Cells Market by Products
- Adult Stem Cells
- Hematopoietic Stem Cells
- Mesenchymal Stem Cells
- Neuronal Stem Cells
- Dental Stem Cells
- Umbilical Cord Stem Cells
- Human Embryonic Stem Cells
- Induced Pluripotent Stem Cells
- Natural Rosette Cells
- Very Small Embryonic Like Stem Cells
- Stem
Cells Market by Technology
- Cell Acquisition
- Bone Marrow Harvest
- Apheresis
- Umbilical Blood Cord
- Cell Production
- Therapeutic Cloning
- In Vitro Fertilization
- Isolation
- Cell Culture
- Cryopreservation
- Expansion and Sub-Culture
- Stem
Cells Market by Applications
- Regenerative Medicine
- Neurological Disorders
- Orthopedics
- Cancer
- Hematological disorders
- Cardiovascular diseases
- Injuries
- Wound Care
- Spinal Cord Injury
- Others (Joint Injuries, Eye Injuries,
Lacerations and Concussions)
- Diabetes
- Liver Disorder
- Incontinence
- Others (Crohn’s Disease, Infertility,
Immunodeficiency Disorder, Organ Transplants, Ophthalmic Disorder)
- Drug Discovery and Development
- Stem
Cells Market by Geography
- North America
- Europe
- Asia
- Rest of the World (RoW)
Buy This Report : http://www.transparencymarketresearch.com/stem-cells-market.html
No comments:
Post a Comment